Vancomycin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

64 API Suppliers, 20 USDMF, 16 CEP/COS, 8 JDMF, 2 EU WC, 14 KDMF, 20 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

335 FDF Dossiers, 145 FDA Orange Book, 76 Europe, 30 Canada, 12 Australia, 14 South Africa, 58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL, CAPSULE;ORAL - EQ 125MG BASE, CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

7 DKSH, 1 Faran Shimi Pharmaceutical, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 6 Actylis, 14 BASF, 2 Finar, 2 Gangwal Chemicals, 3 Lonza Capsugel, 2 Nomisma Healthcare, 1 Pluviaendo, 1 Qualicaps, 6 Roquette, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Empty Capsules, 6 Solubilizers, 6 Parenteral, 6 Film Formers & Plasticizers, 6 Fillers, Diluents & Binders, 5 Controlled & Modified Release, 4 Granulation, 3 Coloring Agents, 3 Taste Masking, 3 Lubricants & Glidants, 1 Direct Compression, 1 Emulsifying Agents, 1 Surfactant & Foaming Agents